Your browser doesn't support javascript.
loading
Mostrar: 20 | 50 | 100
Resultados 1 - 2 de 2
Filtrar
Mais filtros

Base de dados
Ano de publicação
Tipo de documento
Intervalo de ano de publicação
1.
Am J Emerg Med ; 55: 229.e1-229.e3, 2022 05.
Artigo em Inglês | MEDLINE | ID: mdl-35101290

RESUMO

Cardiac tamponade is a rare but possibly fatal complication of blunt thoracic trauma complicated by a sternal fracture. A delayed presentation of cardiac tamponade days or weeks after initial trauma has been described in a few cases. In these cases, the presumed mechanism of cardiac tamponade is pericardial irritation, caused by osseous fragments of the fractured sternum. This case describes a direct mechanical perforation of the right ventricle, caused by a displaced sternal fracture, presenting 5 days after initial trauma. To our knowledge, this mechanism of late cardiac tamponade has not been described in recent literature.


Assuntos
Tamponamento Cardíaco , Fraturas Ósseas , Traumatismos Torácicos , Ferimentos não Penetrantes , Tamponamento Cardíaco/complicações , Tamponamento Cardíaco/etiologia , Fraturas Ósseas/complicações , Ventrículos do Coração/diagnóstico por imagem , Ventrículos do Coração/lesões , Humanos , Esterno/diagnóstico por imagem , Esterno/lesões , Traumatismos Torácicos/complicações , Ferimentos não Penetrantes/complicações
2.
Respir Res ; 21(1): 214, 2020 Aug 12.
Artigo em Inglês | MEDLINE | ID: mdl-32787967

RESUMO

BACKGROUND: Severe asthma (SA) may require frequent courses or chronic use of oral corticosteroids (OCS), inducing many known side effects and complications. Therefore, it is important to identify risk factors of chronic use of OCS in SA, considering the heterogeneity of clinical and inflammatory asthma phenotypes. Another aim of the present analysis is to characterize a subpopulation of severe asthmatics, in whom blood eosinophil counts (BEC) remain elevated despite chronic OCS treatment. METHODS: In a cross-sectional analysis of 982 SA patients enrolled in the Belgian Severe Asthma Registry (BSAR) between March 2009 and February 2019, we investigated the characteristics of the OCS treated patients with special attention to their inflammatory profile. RESULTS: At enrollment, 211 (21%) SA patients were taking maintenance OCS (median dose: 8 [IQR: 5-10]) mg prednisone equivalent). BEC was high (> 400/mm3) in 44% of the OCS treated population. Multivariable logistic regression analysis showed that risk factors for chronic use of OCS in SA were late-onset asthma (i.e. age of onset > 40 yr), frequent exacerbations (i.e. ≥2 exacerbations in the previous year) and non-atopic asthma. Late-onset asthma was also a predictor for persistently high BEC in OCS treated SA patients. CONCLUSION: These data showed a significant association between a persistently high BEC and late-onset asthma in OCS treated SA patients. Whether it is poor compliance to treatment or corticosteroid insensitivity the reasons for this association warrants further investigation.


Assuntos
Corticosteroides/administração & dosagem , Asma/tratamento farmacológico , Asma/epidemiologia , Eosinofilia/epidemiologia , Sistema de Registros , Índice de Gravidade de Doença , Administração Oral , Corticosteroides/efeitos adversos , Adulto , Idoso , Asma/diagnóstico , Bélgica/epidemiologia , Estudos Transversais , Esquema de Medicação , Eosinofilia/induzido quimicamente , Eosinofilia/diagnóstico , Feminino , Humanos , Masculino , Pessoa de Meia-Idade
SELEÇÃO DE REFERÊNCIAS
DETALHE DA PESQUISA